Table 3 Outcome measures of the cohort (n = 68 unless otherwise specified)
From: Outcomes of malignancy in adults with congenital heart disease: a single center experience
Outcome measure | Frequency, n = 68 (%) |
|---|---|
Mortality | 16 (24) |
Cardiac | 3/16 (19) |
Non-Cardiac | 11/16 (69) |
Indeterminate | 2/16 (12) |
MACCEa | 40 (59) |
Arrhythmia | 29 (43) |
Decompensated heart failure | 22 (32) |
Thromboembolism (arterial or venous) | 7 (10) |
Stroke | 3 (4) |
Hospitalization due to MACCE | 34 (50) |
Worsening systemic ventricular function | 9/61 (15) |
Worsening subpulmonary ventricular function | 8/53 (15) |
Worsening valvular function | 25/62 (40) |
Worsening BNP | 28/33 (85) |
Worsening NYHA Functional Class | 19 (28) |
Cardiac transplantationb | 3 (4) |
Cancer Outcome (index malignancy) | |
Progression | 17 (25) |
Relapse | 3 (4) |
Partial Remission | 26 (38) |
Complete Remission | 12 (18) |
Stable and undergoing treatment | 10 (15) |